Insider Transactions in Q1 2026 at Crinetics Pharmaceuticals, Inc. (CRNX)
Insider Transaction List (Q1 2026)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 05
2026
|
Isabel Kalofonos Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
2,500
-74.99%
|
$137,500
$55.0 P/Share
|
|
Jan 05
2026
|
Isabel Kalofonos Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+42.85%
|
$100,000
$40.59 P/Share
|